Tag Biosciences
Wisconsin researchers identify sleep gene
Zeroing in on the core cellular mechanisms of sleep, researchers at University of Wisconsin Medical School have identified for the first time a single gene mutation that has a powerful effect on the amount of time fruit flies sleep.
Plant pathway may treat human disease
A newly discovered pathway by which cells protect themselves from a toxic byproduct of photosynthesis may hold important implications for bioenergy sources, human and plant disease, and agricultural yields, a team of UW–Madison bacteriologists announced Monday in the Proceedings of the National Academy of Sciences.
Citizen panel to release report April 28 on nanotechnology
University of Wisconsin officials will join state legislators in the Assembly Parlor of the State Capitol building on Thursday, April 28, at 11:30 a.m. to accept a report on the promise and perils of nanotechnology produced by a panel of Madison-area citizens.
Bioethicists to ponder biotechnology and the brain
Researchers at UW–Madison will be featured among several experts gathering at the Fourth Annual International Bioethics Forum on Thursday and Friday, April 21 and 22, to discuss a range of ethical issues.
Study finds two brain systems regulate how people call for help
The willingness to call out in distress to get help from others appears to be regulated by two brain systems with very different responsibilities, according to a study by researchers at UW–Madison.
New program simplifies growers’ access to potato varieties
With guidance from Wisconsin's potato growers, the Wisconsin Alumni Research Foundation (WARF) has launched a streamlined licensing program for seed potato farmers who wish to cultivate and sell varieties developed by the potato-breeding program at UW–Madison.
Discovery may halt progression of Alzheimer’s
In a finding that may cause a dramatic shift in the way scientists and researchers search for a therapy for Alzheimer's disease, a team of researchers led by Jeff Johnson, an associate professor at the School of Pharmacy, has discovered that increased expression of a protein called transthyretin in the brain appears to halt the progression of the disease. The findings appear in the current issue of The Journal of Neuroscience.
Licenses for new HyRed cranberry now available
Licenses to produce and sell fruit from UW–Madison's HyRed cranberry - the first publicly developed cranberry variety in more than three decades - are now being offered through the university's patent and licensing organization.
UW part of national pathogen bioinformatics center
In an effort to speed up research on disease-causing pathogens, including ones that could be used as biological weapons, scientists at UW–Madison will team with an information technology (IT) company, SRA International, Inc., to build an online, publicly accessible library of data on these infectious agents and their genomes.
Technology could enhance accuracy of breast biopsy
A new technology developed by a research group headed by Nimmi Ramanujam, assistant professor of biomedical engineering at UW–Madison, will be a "third eye" during breast biopsies and can increase the chance for an accurate clinical diagnosis of breast cancer.
Study: Cancer drug Erbitux nearly doubles survival
Patients with head and neck cancer appear to survive nearly twice as long after receiving a new drug known as Erbitux (scientific name: cetuximab) in conjunction with radiation therapy compared with patients treated solely with radiation therapy.